CN Patent

CN111053751A — 瑞戈非尼的缓释片剂及其制备方法

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2020-04-24 · 6y expired

What this patent protects

本发明公开了一种瑞戈非尼的缓释片剂，其包括：缓释片芯以及包覆所述缓释片芯的肠溶衣；所述缓释片芯包括以下重量比的原辅料：瑞戈非尼15～50份、填充剂15～20份、缓释材料12～30份、助流剂1～3份和润滑剂1～2份。本发明所述的瑞戈非尼缓释片剂为新型释放动力学组合的瑞戈非尼缓释片组合物。

USPTO Abstract

本发明公开了一种瑞戈非尼的缓释片剂，其包括：缓释片芯以及包覆所述缓释片芯的肠溶衣；所述缓释片芯包括以下重量比的原辅料：瑞戈非尼15～50份、填充剂15～20份、缓释材料12～30份、助流剂1～3份和润滑剂1～2份。本发明所述的瑞戈非尼缓释片剂为新型释放动力学组合的瑞戈非尼缓释片组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111053751A
Jurisdiction
CN
Classification
—
Expires
2020-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.